𝔖 Bobbio Scriptorium
✦   LIBER   ✦

XK469, a novel antitumor agent, inhibits signaling by the MEK/MAPK signaling pathway

✍ Scribed by Hong Lin; Balanehru Subramanian; Alex Nakeff; Ben D. Chen

Book ID
105991605
Publisher
Springer
Year
2002
Tongue
English
Weight
172 KB
Volume
49
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitotic arrest induced by XK469, a novel
Mitotic arrest induced by XK469, a novel antitumor agent, is correlated with the inhibition of cyclin B1 ubiquitination
✍ Hong Lin; Xiang Y. Liu; Balanehru Subramanian; Alexander Nakeff; Fred Valeriote; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 247 KB

## Abstract XK469 (NSC 697887) is a novel antitumor agent with broad activity against a variety of tumors. Previous studies suggest that XK469 is a topoisomerase IIβ poison with functional activity similar to that of 4′‐(9‐acridinylamino) methanesulfon‐m‐anisidide (__m__‐AMSA). The goal of our stud

Lipolysis is stimulated by PEGylated con
Lipolysis is stimulated by PEGylated conjugated linoleic acid through the cyclic adenosine monophosphate-independent signaling pathway in 3T3-L1 cells: Activation of MEK/ERK MAPK signaling pathway and hyper-secretion of adipo-cytokines
✍ Hyun-Seuk Moon; Hong-Gu Lee; Ji-Hye Seo; Ding-Ding Guo; In-Yong Kim; Chung-Soo C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

## Abstract We previously reported that PEGylated conjugated linoleic acid (PCLA) as a pro‐drug treatment of cultures of 3T3‐L1 cells containing differentiated adipocytes caused de‐differentiation by downregulation of PPARγ2‐induced adipogenesis, and cell apoptosis induced by PCLA was lower than th